Transcript Strategies to improve the acceptance and use of generics.

Strategies to improve the
acceptance and use of generics.
Jordan Pharmaceutical
Association
Dr.Taher Shakhashir
• Introduction to Pharmaceutical Association.
• HAI data analysis.
• Situation of pharmaceuticals in Jordan
• Generic Strategy proposal.
2
1957 - 2007
3
Jordan Pharmaceutical Association
•
Established in 1957 celebrating our 50th anniversary.
•
Profession is highly regulated and governed by the
“Law of Pharmacy & Drugs” of 2001.
•
The JPA is run by an elected board.
•
Membership in JPA: around 10100 registered
pharmacists and most of them are active practicing
pharmacists.
4
Jordan Pharmaceutical Association
• Number of pharmacies: 1958 employing
3500.
• Number of drugstores: 317 employing
4500
• Number of manufacturing plants: 16
employing 8000
5
Jordan Pharmaceutical Association
• 1950 - 1990 :
2559 Pharmacists
• 1991 – 2001 :
5022 Pharmacists
• 2002 – Now :
6
3102 Pharmacists
Jordan Pharmaceutical Association
• Males represent:
53%
• Females represent: 47%
7
HAI data
•
•
•
According to HAI data(2003),
approximately 70% of the
population is covered by health
insurance, provided by:
Ministry of Health
(21%)
Royal Medical Services (33%),
Refugee missions
(18%),
Private insurance
(10%).
=========== Total of 82 %
insured ….. Not 70% !!!!!
i
8
18
21
10
MOH
DRMS
18
33
Refugee
Mission
Private
Insurance
No Insurance
coverage
HAI data analysis
•
The study was performed in 2003/2004, before implementing the
new pricing guidelines.
(JFDA Pricing regulations are used as a reference in
neighbouring countries).
•
Total Market consumption is directly affected by the following
conditions in the area:
»
»
»
»
9
Jordan is one of the main destinations for MENA for
Medical Tourism.
Iraqi crisis: number of Iraqis in Jordan, and medicine
export to Iraq.
Palestinian crisis: Mobile hospitals, medicine donations.
International UN forces, and the accompanied Jordanian
Hospitals.
•
2004:
HAI data analysis
» Total pharmaceutical market: JD 140 millions
- Imported: JD 105 millions (export price)
- Local manufacturing: JD 35 millions (25% of total
market)
» GDP: JD 8.1 Billions
» Pharmaceutical consumption is: 1.87% of GDP.
18.4% of total health
expenditure.
» These figures include Export to Iraq, Palestine, UN
international forces and Health tourism.
10
» Refs: J-FDA statistical data,
HAI data.
HAI data analysis
2006:
» Total pharmaceutical market: JD 220 millions:
- Imported: JD 165 millions (export price)
- Local manufacturing: JD 55 millions (25% of total
market)
» GDP: JD 10.3 Billions
» Pharmaceutical consumption is: 2.13% of GDP.
22.7% of total health
expenditure.
» These figures include Export to Iraq, Palestine, UN
international forces and Health tourism.
11
»
Refs: J-FDA statistical data,
HAI data.
HAI data analysis
In 2006
New age groups were covered by MOH insurance:
Population
Population
0-6 years: 901,000
> 65 years: 240,000
Ref: Jordan Department of Statistics
12
22% of population
2007
ُEstimated
population 2007
Jordanian citizens
Population
5723000
5282300
percentage
100
92.3
Non Jordanians
440700
7.7
Population age
0 – 6 years
1011250
17.7
Population
over 60 yrs
296450
5.2
13
Ref: Jordan Department of Statistics
2007
• Insured Jordanians before addition of new
age groups: 82%
• New age groups insured: 4.1 % (0-6 &
>65)
• Total insured Jordanians : 86.1 % (of total
population including visitors)
• Total insured Jordanians : 93.3 % (of total
population Excluding visitors)
14
HAI data analysis
– Although Jordan is classified as a developing
country ,yet its medical services are up to the
standard of developed countries.
» Leader in MENA in health services.
» High caliber of medical professionals.
» State of the art facilities and services.
» Continuous education.
15
HAI data analysis
• IVF : leading centers globally.
• Open Heart Surgeries
• Cancer treatment
16
Situation in Jordan.
• The Pharmaceutical Industry is highly
advanced in branded generics, ranked 2nd in
export.
• Over 8000 well trained employees.
• Exports over $ 400 mill.
• Local market share: 25-30% ( value).
• Compared to EU generic % in their local market
Germany 21% value •
UK 18% value •
Denmark 35% Value •
Spain 3,3% value •
17
Ref: EU generic manufacturing Association
Situation in Jordan.
»Insurance covers:
– Cancer Treatment 100%.
– Kidney Dialysis.
– Multiple Sclerosis (MS)
– Vaccination of all children 100%.
– Thalassemia.
– HIV, AIDS.
18
Jordan expenditure is moderate
Moderate
19
Jordan out of pocket is far less than
18%
Jordan, less
than 6.7%
20
Our main goal is:
• Safety.
• Quality
• Efficacy.
• Availability.
• Affordability.
21
Stakeholders
Government
Physician
Pharmacist
Patient
22
Recommendations to enhance branded
generics
• Government:
– Support the procurement policies
– Cancel import duties and VAT.
– Establish proper guidelines & protocols
for dispensing medicines.
23
Recommendations to enhance branded
generics
• Government:
– Run cost effective studies for therapeutic
classes.
– Upgrade networking of insured population to
avoid duplication of dispensing medicines.
– Continuous proper training of MOH medical
health providers.
– Speed up registration of reliable generic
pharmaceutical manufacturers, emphasizing:
Safety, Quality, Efficacy.
24
Recommendations to enhance branded
generics
• Physicians:
– Encourage physicians to prescribe generics.
• Consumers:
– Improve awareness towards efficacy and
availability of generics.
25
Recommendations to enhance branded
generics
• Pharmacists:
– Implementation of Good Pharmacy Practice
(GPP).
– Implementation of Code of Ethics in medical
promotion.
– Raising awareness towards counterfeit drugs.
26
In conclusion
• We need to:
– Provide high quality affordable medicine.
– Support Jordan`s mission to promote medical
tourism.
– Support local pharmaceutical industries.
– Encourage availability of new therapeutic
medications to match the high level of health
services in developed countries.
– Raise awareness among health care
providers and patients regarding generics.
27
THANK YOU
28